U-M researchers conducted first human trials of ketamine

Author | Lauren Talley

Close-up of a nurse's hands holding a syringe of ketamine that she is attaching to IV tubing
Photo by Leisa Thompson

Before it was studied as a treatment for depression and chronic pain, scientists developed ketamine as a safer alternative to an earlier anesthetic, PCP.

In the 1960s, chemists at Detroit-based pharmaceutical company Parke-Davis reached out to U-M to study ketamine.

In 1965, U-M pharmacology professor emeritus Edward F. Domino and anesthesiology professor Guenter Corssen published results of the first human trial of ketamine. The 20 subjects had good blood pressure, respiration rate, and other vital signs. And the risk of death was significantly lower compared to other general anesthetics available at the time.

Domino and Corssen also collaborated on the first clinical trial of ketamine. They published results in 1966 showing ketamine was a safe anesthetic in the 130 subjects undergoing surgery. Because of its short-acting pain-relieving properties, ketamine became a widely-used battlefield anesthetic in the Vietnam War.

The subjects of the 1965 study were people incarcerated at Jackson State Prison. The study was overseen by an ethics committee, and in 2017 Domino said, “To this day, NIH guidelines for prison research are based on what happened here.”

Sources:
Garber, Ken. “Listening to Ketamine: An anesthetic with Michigan roots is pulling people from the depths of depression.” Ann Arbor Observer, November 2022

Denomme, Nicholas. “The Domino Effect: Ed Domino’s early studies of Psychoactive Drugs.” Journal of Psychoactive Drugs, 50:4, 298-305,DOI: 10.1080/02791072.2018.1506599
Featured News & Stories Group photo of roughly 100 people holding up letters that spell "Stomp Out Sarcoma" in a grassy, wooded area.
Philanthropy News
Annual 5K event builds awareness and support for rare cancer research
The Stomp Out Sarcoma 5K joins patients, survivors, care providers, and loved ones to raise funds and awareness for sarcoma research at the U-M Rogel Cancer Center.
 Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Early Release: Tips for Surviving the Heat
Extreme heat, especially in places that don't experience it often, can be dangerous - especially to people with certain health conditions. In this episode, Dr. Brad Uren shares tips for weathering extreme heat.
 stethoscope close up black and wood table
Health Lab
Affordable Care Act preventive services mandate key to transforming hepatitis C treatment
In an article researchers describe two potential futures: one in which 90% of hepatitis C cases in the United States are cured within five years and another in which the status quo of insufficient screening rates worsen in the absence of the ACA coverage mandate.
 woman holding pole in bathroom with patient gown on
Health Lab
Older adults vary widely in preparing to “age in place”
Aging in place, or staying in your own home as you grow older, is key goal for many older adults, but a poll shows wide variation in what people over 65 are doing to prepare.
 man showing device in his hand smiling with blue gloves on
Health Lab
First-of-its-kind therapeutic device saves child in septic shock with multiorgan failure
The selective cytopheretic device, created by scientists and doctors at Michigan Medicine, is a first-in-class autologous immune cell directed therapy and successfully treated a young patient in septic shock and multiorgan failure.
 moving image of restroom sign and background is two different yellows and moving like a subtle wave
Health Lab
How holding your pee can rewire your brain
Could fighting the urge to pee cause health issues? A urologist discusses how it might rewire your brain and stretch your bladder.